Skip to content
Home/Companies/Biotech/Insempra

Insempra

Biotech·Germany·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Insempra?

Insempra is currently owned by Possible Ventures through Possible Ventures Fund III (2023 vintage), since 2024. Across its history, Insempra has been through 5 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Possible Ventures
Most recent investor
Possible Ventures
Possible Ventures Fund III · 2023 · VC
5 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive
Key takeaways
  • ·Co-held by BlueYard Capital, Bayern Kapital, EQT Ventures, Henkel Ventures and Possible Ventures since 2020.
  • ·5 distinct PE sponsors across ownership cycles.

Ownership history

5 ownership periods · co-invest detected

Active
Co-held by BlueYard Capital, Bayern Kapital, EQT Ventures, Henkel Ventures and Possible Ventures since 2020.
Co-invest · 5 holders · 2020 · present
BlueYard Capital
BlueYard CapitalActive
2020 · present(6yr) · BlueYard Capital Fund II · 2019 · VC
EQT Ventures
EQT VenturesActive
2021 · present(5yr) · EQT Ventures II · 2019 · VC
Bayern Kapital
Bayern KapitalActive
2021 · present(5yr) · Wachstumsfonds Bayern · 2009 · VC
Possible Ventures
Possible VenturesActive
2024 · present(2yr) · Possible Ventures Fund III · 2023 · VC
Henkel Ventures
Henkel VenturesActive
2024 · present(2yr) · Henkel Ventures Balance-Sheet Vehicle · 2017 · Evergreen

More from Possible Ventures Fund III

Other portfolio companies in the same fund.

Coherence Neuro
Active
BiotechUK· 2025
Telura Energy
Telura Energy
Active
EnergyGermany· 2025
Cosmic Aerospace
Cosmic Aerospace
Active
MobilityUS· 2024
HyperHeat
HyperHeat
Active
ClimateTechGermany· 2024
Automata
Automata
Active
IndustrialsUK· 2023
Chemify
Chemify
Active
Deep TechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Insempra

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Insempra?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Insempra.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue